| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/16/2008 | WO2008124165A2 Self-assembling nanoparticle drug delivery system |
| 10/16/2008 | WO2008124086A2 Chimeric activators: quantitatively designed protein therapeutics and uses thereof |
| 10/16/2008 | WO2008123918A1 Cellular compositions for the treatment of kidney disease and uses thereof |
| 10/16/2008 | WO2008123625A1 Method for activating receptor by cofactor and method for utilizing ligand activity |
| 10/16/2008 | WO2008123622A1 Modified microorganism |
| 10/16/2008 | WO2008123308A1 Therapeutic agent comprising vasohibin |
| 10/16/2008 | WO2008123180A1 Method for detection of target substance, and tag, dna, vector, probe and detection kit for use in the method |
| 10/16/2008 | WO2008122789A2 Methods for modulating lrrk2 |
| 10/16/2008 | WO2008122769A2 Adenoviral vector encoding malaria antigen |
| 10/16/2008 | WO2008122687A1 Protein gp120 polypeptide capable of inhibiting the life cycle of the aids virus |
| 10/16/2008 | WO2008122435A2 Use gene variants of the human meis1, btbd9, map2k5, lbxcor1, ptprd or a2bp1 gene for diagnostic and therapeutic approaches to restless legs syndrome (rls) |
| 10/16/2008 | WO2008122434A1 Bis-met histones |
| 10/16/2008 | WO2008122294A1 Peptides, antibodies and fragments thereof for the treatment and diagnostic of celiac disease |
| 10/16/2008 | WO2008122089A1 Method of purifying recombinant peptides by selective precipitation |
| 10/16/2008 | WO2008100578A3 Method of isolating antibodies by precipitation |
| 10/16/2008 | WO2008099178A3 Binding members for ige molecules |
| 10/16/2008 | WO2008091408A3 Circulating renalase and methods of increasing same |
| 10/16/2008 | WO2008089756A3 Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis |
| 10/16/2008 | WO2008088548A3 Disintegrin variants and pharmaceutical uses thereof |
| 10/16/2008 | WO2008079270A3 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis |
| 10/16/2008 | WO2008070586A3 Compositions and methods for treatment of protein misfolding and protein aggregation diseases |
| 10/16/2008 | WO2008063493A3 Compositions and methods related to toll-like receptor-3 |
| 10/16/2008 | WO2008060483A3 Protein-protein interaction biosensors and methods of use thereof |
| 10/16/2008 | WO2008058547A3 Alpha-lactalbumin composition |
| 10/16/2008 | WO2008055059A3 Bi-functional peptides for multiple sclerosis treatment and diagnosis |
| 10/16/2008 | WO2008045489A3 Glucoamylase variants with altered properties |
| 10/16/2008 | WO2008033888A3 Methods for administering long-lasting hypoglycemic agents |
| 10/16/2008 | WO2007149880A3 Crystal structure of ox40l and ox40l complexed with ox40 receptor |
| 10/16/2008 | WO2007139982A3 Methods and compositions for gene inactivation |
| 10/16/2008 | WO2007133373A3 TNF-α VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-α |
| 10/16/2008 | WO2007127524A8 Mutations and polymorphisms of insr |
| 10/16/2008 | WO2007115230A3 A strategy for homo- or hetero-dimerization of various proteins in solutions and in cells |
| 10/16/2008 | WO2007092704A8 Genes for enhancing nitrogen utilization efficiency in crop plants |
| 10/16/2008 | WO2007087576A3 Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases |
| 10/16/2008 | WO2007012944A9 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 10/16/2008 | WO2007005627A8 Tuberculosis antigen detection assays and vaccines |
| 10/16/2008 | WO2006138324A3 Treponema pallidum antigens for vaccine development and diagnostic tests |
| 10/16/2008 | WO2006078717A3 Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis |
| 10/16/2008 | US20080256670 AtRSp gene promoters |
| 10/16/2008 | US20080256663 Nucleic acid molecules and other molecules associated with plants |
| 10/16/2008 | US20080256662 Nucleic acid molecules and other molecules associated with plants |
| 10/16/2008 | US20080256650 Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression |
| 10/16/2008 | US20080255340 Mixture comprising stabilized neovascularization protein; for use in management of hypertension, hyperlipidemia, diabetes and chronic fatigue syndrome |
| 10/16/2008 | US20080255339 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities |
| 10/16/2008 | US20080255252 Infectious Aetiology of Prostatic Disease and Methods to Identify Causative Agents |
| 10/16/2008 | US20080255051 Use to treat dyslipidemic disorders, stroke and myocardial infarction; isolated polypeptide of given sequence; labeled peptide for use in visualization of plaque |
| 10/16/2008 | US20080255046 Y2 Selective Receptor Agonists for Therapeutic Interventions |
| 10/16/2008 | US20080255045 Modified FGF-21 Polypeptides and Their Uses |
| 10/16/2008 | US20080255040 Polypeptide with amino acid sequences including exogenous glycosylated sequences; libraries |
| 10/16/2008 | US20080255039 Peptide which is part of epitope in human IL-15 responsible for high-affinity binding of IL-15 to IL-15Ralpha chain, characterized in that it has sequence of region of human mature wild-type IL-15 from L44 to L52, or sequence of region of human mature wild-type IL-15 from E64 to I68 or from E64 to L69 |
| 10/16/2008 | US20080255028 Collagen Receptor I-Domain Binding Modulators |
| 10/16/2008 | US20080254551 Using support immobilized immunmoglobulin fusions as separation and classification tools in screening fluids for preferential analytes |
| 10/16/2008 | US20080254547 Supracolonic aerodigestive neoplasm detection |
| 10/16/2008 | US20080254528 Baculovirus Expression System |
| 10/16/2008 | US20080254519 Via dioxygenases; proteins; genes |
| 10/16/2008 | US20080254510 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 10/16/2008 | US20080254507 Multimeric human immunodeficiency viricidal agent |
| 10/16/2008 | US20080254506 Claudin polypeptides |
| 10/16/2008 | US20080254484 Using site directed mutagenesis to generate acyl lipid hydrolase with decreased allergenicity; insecticides; immunotherapy; nutritional supplements |
| 10/16/2008 | US20080254475 Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of a nematode gene |
| 10/16/2008 | US20080254466 Heregulin-like Factor |
| 10/16/2008 | US20080254449 Nucleotide sequences for use as probes in detection of shiga toxin bacteria |
| 10/16/2008 | US20080254200 Wheat protein and methods of production |
| 10/16/2008 | US20080254145 Anti-tumor drug, medicament, composition, and use thereof |
| 10/16/2008 | US20080254070 Bacterial secreted protein for use in generating vaccine for prevention of streptococcal infection; immunotherapy |
| 10/16/2008 | US20080254050 Immunotherapeutic comprising very small particles from neisserial outer memebrane protein and/or vascular endothelial growth factor for use in targeting a nd treating cell proliferative, inflammatory autoimmune and vision defects |
| 10/16/2008 | US20080254048 He4 monoclonal antibodies and methods for their use |
| 10/16/2008 | US20080254042 Using prolactin-releasing peptide (PrRP) to identify modulators for prevention and treatment of nervous system, heart, hepatic and anxiety disorders |
| 10/16/2008 | US20080254035 Expression vector comprising lipocalin gene sequences for use in prevention and treatment of cell proliferative, inflammatory, autoimmune and cardiovascular disorders |
| 10/16/2008 | US20080254034 Microbial membrane protein for use in diagnosis, prevention and treatment of gramnegative bacterial infection |
| 10/16/2008 | US20080254033 Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases |
| 10/16/2008 | US20080254032 Colony stimulating bfcator specific monoclonal antibody for use in diagnosis, prevention and treatment of infcetion, cell proliferative, inflammatory, autoimmune, arthritic, skin, respiratory and nervous system disorders |
| 10/16/2008 | US20080254031 Nucleotide sequences coding tumor antigens for use as diagnostic tool in detection and staging of cell proliferative disorders |
| 10/16/2008 | US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders |
| 10/16/2008 | US20080254025 Using interleukin-1( IL-1) specific immunoglobulin for diagnosis, prevention and treatment of osteoarthritic, inflammatory, respiratory and autoimmune disorders |
| 10/16/2008 | US20080254019 Therapeutic Agents and Therapeutic Methods For Treating Injured Tissue |
| 10/16/2008 | US20080253993 Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope |
| 10/16/2008 | US20080253992 Using hydrophobic interaction chromatography to recover therapeutic fusion protein for use in treatment of injuries associated with ischemia, trauma, inflammation and contact with toxic substances |
| 10/16/2008 | US20080253991 Using glutamic acid decarboxylase (GAD) autoantigen, cd3 specific antibodies and lymphocyte specific antibodies to treat and prevent new onset type I diabetes in mammals |
| 10/16/2008 | CA2688619A1 Means and methods for haplotyping mhc-drb loci in mammals and uses thereof |
| 10/16/2008 | CA2683679A1 Adenoviral vector encoding malaria antigen |
| 10/16/2008 | CA2683143A1 Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants |
| 10/16/2008 | CA2683063A1 Self-assembling nanoparticle drug delivery system |
| 10/16/2008 | CA2682887A1 Bis-met histones |
| 10/16/2008 | CA2682675A1 Detection of anaplasma platys |
| 10/16/2008 | CA2682623A1 Peptides, antibodies and fragments thereof for the treatment and diagnostic of celiac disease |
| 10/15/2008 | EP1980618A2 Human DNASE I variants |
| 10/15/2008 | EP1980617A1 Improved expression of HIV polypeptides and production of virus-like particles |
| 10/15/2008 | EP1980616A2 E.Coli 0157: H7 C1 esterase inhibitor-binding protein STCE and uses thereof |
| 10/15/2008 | EP1980615A1 Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell |
| 10/15/2008 | EP1980573A2 Isolated dendritic cell membrane protein genes |
| 10/15/2008 | EP1980572A1 Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders |
| 10/15/2008 | EP1980571A1 Anti-tumor drug, medicament, composition, and use thereof |
| 10/15/2008 | EP1980269A1 Prevention of staphylococcus biofilm formation |
| 10/15/2008 | EP1980268A2 Vaccination methods against avian influenza virus |
| 10/15/2008 | EP1980267A1 S. pneumoniae transcytosis protein |
| 10/15/2008 | EP1979742A2 Methods of in vitro propagation and detection of infectious prion |
| 10/15/2008 | EP1979488A2 Immunostimulatory combinations of tnfrsf, tlr, nlr, rhr, purinergic receptor, and cytokine receptor agoinsts for vaccines and tumor immunotherapy |
| 10/15/2008 | EP1979484A1 Use of stomatin (stm1) polynucleotides for achieving a pathogen resistance in plants |
| 10/15/2008 | EP1979377A2 Dendritic cell specific transcription regulator dc-script and uses thereof |